SFM
RVLP

Sphera Funds Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Sphera Funds Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-864,006
Closed -$3.11M – 116
2019
Q1 		$3.11M Sell
864,006
-58,194
-6% -$428K 0.28% 75
2018
Q4 		$7.15M Buy
+922,200
New +$7.38M 0.81% 31

Other funds holding RVLP

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sphera Funds Management's RVLP Position: Q2 2019 in Review

Sphera Funds Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2019, closing a stake of 864,006 shares — an estimated $3.11M sold.

Sphera Funds Management first reported a position in RVLP in Q4 2018 and held it in 2 quarters. The position peaked at $7.15M in Q4 2018. 42 funds tracked by Wall St. Rank hold RVLP as of Q2 2019.

  • Sphera Funds Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2019 after selling out during the quarter.
  • Sphera Funds Management sold 864,006 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2019, an estimated $3.11M.
  • Sphera Funds Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 2 quarters.
  • Sphera Funds Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $7.15M in Q4 2018.
  • 42 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.